RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of R...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4182493?pdf=render |
_version_ | 1818612389445107712 |
---|---|
author | Fang-Nan Song Meng Duan Long-Zi Liu Zhi-Chao Wang Jie-Yi Shi Liu-Xiao Yang Jian Zhou Jia Fan Qiang Gao Xiao-Ying Wang |
author_facet | Fang-Nan Song Meng Duan Long-Zi Liu Zhi-Chao Wang Jie-Yi Shi Liu-Xiao Yang Jian Zhou Jia Fan Qiang Gao Xiao-Ying Wang |
author_sort | Fang-Nan Song |
collection | DOAJ |
description | Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of RANK in HCC tissue (n = 398). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to examine the expression of RANK, E-cadherin, N-cadherin, vimentin, Snail, Slug, Twist and MMPs in HCC cells. Wound healing and Transwell assays were used to evaluate cell migration and invasion ability.We found that expression of RANK, the receptor of RANKL, was significantly higher in HCC tumor tissues than in peritumor liver tissues (p<0.001). Constitutive expression of RANK was detected in HCC cell lines, which can be up-regulated when HCC cells were stimulated with RANKL. Notably, in vitro experiments showed that activation of RANKL-RANK axis significantly promoted migration and invasion ability of HCC cells. In addition, RANKL stimulation increased the expression levels of N-cadherin, Snail, and Twist, while decreased the expression of E-cadherin, with concomitant activation of NF-κB signaling pathway. Moreover, administration of the NF-κB inhibitor attenuated RANKL-induced migration, invasion and epithelial-mesenchymal transition of HCC cells.RANKL could potentiate migration and invasion ability of RANK-positive HCC cells through NF-κB pathway-mediated epithelial-mesenchymal transition, which means that RANKL-RANK axis could be a potential target for HCC therapy. |
first_indexed | 2024-12-16T15:45:27Z |
format | Article |
id | doaj.art-fb22b85191044f309ce9b3eb2fa0fc3d |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-16T15:45:27Z |
publishDate | 2014-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-fb22b85191044f309ce9b3eb2fa0fc3d2022-12-21T22:25:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10850710.1371/journal.pone.0108507RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.Fang-Nan SongMeng DuanLong-Zi LiuZhi-Chao WangJie-Yi ShiLiu-Xiao YangJian ZhouJia FanQiang GaoXiao-Ying WangMetastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of RANK in HCC tissue (n = 398). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to examine the expression of RANK, E-cadherin, N-cadherin, vimentin, Snail, Slug, Twist and MMPs in HCC cells. Wound healing and Transwell assays were used to evaluate cell migration and invasion ability.We found that expression of RANK, the receptor of RANKL, was significantly higher in HCC tumor tissues than in peritumor liver tissues (p<0.001). Constitutive expression of RANK was detected in HCC cell lines, which can be up-regulated when HCC cells were stimulated with RANKL. Notably, in vitro experiments showed that activation of RANKL-RANK axis significantly promoted migration and invasion ability of HCC cells. In addition, RANKL stimulation increased the expression levels of N-cadherin, Snail, and Twist, while decreased the expression of E-cadherin, with concomitant activation of NF-κB signaling pathway. Moreover, administration of the NF-κB inhibitor attenuated RANKL-induced migration, invasion and epithelial-mesenchymal transition of HCC cells.RANKL could potentiate migration and invasion ability of RANK-positive HCC cells through NF-κB pathway-mediated epithelial-mesenchymal transition, which means that RANKL-RANK axis could be a potential target for HCC therapy.http://europepmc.org/articles/PMC4182493?pdf=render |
spellingShingle | Fang-Nan Song Meng Duan Long-Zi Liu Zhi-Chao Wang Jie-Yi Shi Liu-Xiao Yang Jian Zhou Jia Fan Qiang Gao Xiao-Ying Wang RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. PLoS ONE |
title | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. |
title_full | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. |
title_fullStr | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. |
title_full_unstemmed | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. |
title_short | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. |
title_sort | rankl promotes migration and invasion of hepatocellular carcinoma cells via nf κb mediated epithelial mesenchymal transition |
url | http://europepmc.org/articles/PMC4182493?pdf=render |
work_keys_str_mv | AT fangnansong ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT mengduan ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT longziliu ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT zhichaowang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT jieyishi ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT liuxiaoyang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT jianzhou ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT jiafan ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT qianggao ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition AT xiaoyingwang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition |